Researchers have found a tiny antibody can be used to combat novel coronavirus in mices. The human clinical trials have not yet started.
Researchers have found a tiny antibody can be used to combat novel coronavirus in mices. The human clinical trials have not yet started.Scientists of the University of Pittsburg claim that they have found a drug that could treat the new coronavirus by isolating the smallest biological molecule to date. The antibody component, which is ten times smaller than a full-sized antibody, has been used to construct a drug known as Ab8 for potential use as a therapeutic and prophylactic against the virus. The researcher's reported that Ab8 is highly effective in preventing infection in mice and hamsters. They said that it wouldn't have negative side-effects on people. However, the vaccine has been tested only on mice and hamsters, and it is too early to say that the vaccine will work on humans. The efficacy of the vaccine can be determined after large trials.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.
Copied!